Chardan’s 5th Annual Genetic Medicines Conference - Virtual Conference
October 4-5, 2021

Chardan’s 5th Annual Genetic Medicines Conference was held virtually on October 4-5, 2021. The conference is the largest sell-side hosted event focused exclusively on Genetic Medicines, featuring more than 80 public and private genetic medicines companies and thought leaders.

The conference includes two full days of programming featuring companies, panels and perspectives from groundbreaking thought leaders such as Dr. George Church, Dr. Jennifer Doudna, Dr. Art Levin, Dr. Billy Li, and Dr. Jim Wilson.

Key Panels from our 5th Annual Virtual Genetic Medicines Conference:

• AAV Gene Therapy: Advancing Preclinical Assets for Diabetes and Other Metabolic Diseases featuring Hans Sollinger, MD, PhD, Endsulin, Sukumar Nagendran, MD, Jaguar Gene Therapy, Joe Nolan, Jaguar Gene Therapy, and Shankar Ramaswamy, MD, Kriya Therapeutics
• AAV Gene Therapy: featuring Jim Wilson, MD, PhD
• CRISPR Gene Editing: featuring Jennifer Doudna, PhD
• Genetic Medicines: The Ongoing Emergence of the Heart as a Target Tissue featuring Samir Ounzain, PhD, HAYA Therapeutics, Magdalene Cook, MD, Renovacor, Matt Killeen, PhD, Renovacor, Marc Semigran, MD, Renovacor, Jonathan Schwartz, MD, Rocket Pharmaceuticals, Gaurav Shah, MD, Rocket Pharmaceuticals, Faraz Ali, Tenaya Therapeutics, and Sekar Kathiresan, MD, Verve Therapeutics
• The Next Big Thing in Vector Gene Therapy—Non-traditional Vectors and Gene Regulation featuring Whitney Ijem, Krystal Biotech, Krish Krishnan, Krystal Biotech, Zandy Forbes, PhD, MeiraGTx, and Tuyen Ong, MD, Ring Therapeutics
• SPAC IPO Strategies featuring Dr. Gbola Amusa, Chardan Partner and Chief Scientific Officer, George Kaufman, Chardan Partner and Head of Investment Banking, and David Lederman Managing Director, Equity Capital Markets at Chardan.
• Gene Editing: Next-generation Technologies Worth Watching featuring Devyn Smith, PhD, Arbor Biotechnologies, Rachel Haurwitz, PhD, Caribou Biosciences, Mitch Finer, PhD, LifeEDIT Therapeutics, Simon Harnest, Metagenomi, Brian Thomas, PhD, Metagenomi, Benjamin Oakes, PhD, Scribe Therapeutics
• RNA: RNA-based Targeted Delivery Approaches featuring Sarah Boyce, Avidity Biosciences, Art Levin, PhD, Avidity Biosciences, Denise Bevers, DTx Pharma, Arthur Suckow, PhD, DTx Pharma, Oxana Beskrovnaya, PhD, Dyne Therapeutics, Josh Brumm, Dyne Therapeutics, Stephen Squinto, PhD, Gennao Bio, and David Lockhart, PhD, ReCode Therapeutics
• Cell Therapies and Multiplex Germline Engineering featuring Dr. George Church

Replays & Research
Select companies that webcasted their presentations, as well as many of the KOL fireside chats and panels are available for replay. Please feel free to reach out with what you are interested in hearing. In addition, post-conference published research is also available upon request.  

Read the post-conference published research here https://chardanlibrary.bluematrix.com/client/login.jsp or contact corpaccess@chardan.com to request access to replays and research.

**This event is for current or prospective relationships of Chardan. If you would like to request more information contact corpaccess@chardan.com.